MX2012002716A - Material no viable derivado de probioticos para la prevencion y tratamiento de la alergia. - Google Patents

Material no viable derivado de probioticos para la prevencion y tratamiento de la alergia.

Info

Publication number
MX2012002716A
MX2012002716A MX2012002716A MX2012002716A MX2012002716A MX 2012002716 A MX2012002716 A MX 2012002716A MX 2012002716 A MX2012002716 A MX 2012002716A MX 2012002716 A MX2012002716 A MX 2012002716A MX 2012002716 A MX2012002716 A MX 2012002716A
Authority
MX
Mexico
Prior art keywords
composition
treatment
allergic
disclosed
derived non
Prior art date
Application number
MX2012002716A
Other languages
English (en)
Other versions
MX345077B (es
Inventor
Udo Herz
Harald Renz
Holger Garn
William Michael Russell
Eric A F Van Tol
Machtelt Braaksma
Maria Johanna Van Der Werf
Karin M Overkamp
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of MX2012002716A publication Critical patent/MX2012002716A/es
Publication of MX345077B publication Critical patent/MX345077B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención describe un proceso para la preparación de una composición probiótica no viable que tiene propiedades antialérgicas (es decir preventivas de la alergia y/o antialérgicas en el sentido terapéutico), el proceso comprende las etapas de: (a) someter el LGG a cultivo en un medio de cultivo adecuado utilizando un proceso por lotes; (b) recolectar el sobrenadante del cultivo en una fase exponencial tardía de la etapa de cultivo, (c) remover los contenidos líquidos del sobrenadante del cultivo para obtener la composición. También se describe una composición que comprende una mezcla proteinácea, la composición se puede obtener por el proceso anterior, y el uso de la misma en un producto dietético, preferentemente teniendo como objetivo a las madres embarazadas, los bebés, o los niños, así como a la aplicación en un alimento para propósitos médicos específicos.
MX2012002716A 2009-09-11 2010-09-10 Material no viable derivado de probioticos para la prevencion y tratamiento de la alergia. MX345077B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09170124A EP2295535A1 (en) 2009-09-11 2009-09-11 Probiotic material
PCT/NL2010/050576 WO2011031149A1 (en) 2009-09-11 2010-09-10 Probiotic derived non-viable material for allergy prevention and treatment

Publications (2)

Publication Number Publication Date
MX2012002716A true MX2012002716A (es) 2012-04-19
MX345077B MX345077B (es) 2017-01-16

Family

ID=41561153

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002716A MX345077B (es) 2009-09-11 2010-09-10 Material no viable derivado de probioticos para la prevencion y tratamiento de la alergia.

Country Status (20)

Country Link
US (1) US20110217402A1 (es)
EP (2) EP2295535A1 (es)
JP (1) JP2013504321A (es)
KR (1) KR20120061836A (es)
CN (1) CN102575224A (es)
AU (1) AU2010293145B2 (es)
BR (1) BR112012005533A2 (es)
CA (1) CA2772593C (es)
EC (1) ECSP12011786A (es)
ES (1) ES2614929T3 (es)
IN (1) IN2012DN00951A (es)
MX (1) MX345077B (es)
MY (1) MY160646A (es)
NZ (1) NZ597818A (es)
PE (1) PE20121557A1 (es)
PL (1) PL2475764T3 (es)
RU (1) RU2012114190A (es)
SG (1) SG178230A1 (es)
TW (1) TWI595090B (es)
WO (1) WO2011031149A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095189A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) * 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
AU2015261869A1 (en) * 2014-05-20 2016-11-17 Biogaia Ab Neonatal microbiome supplementation
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
JP7057059B2 (ja) 2016-08-22 2022-04-19 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
CN111315413A (zh) * 2017-11-07 2020-06-19 秀比特生物技术公司 通过IgE类特异性免疫反应的抑制效果阻止婴儿期变态反应素质获得的方法
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
KR100321543B1 (ko) 1991-01-24 2002-09-12 마르텍 코포레이션 미생물-기원오일혼합물및이의용도
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
CA2206674A1 (en) * 1996-05-30 1997-11-30 Gregor Reid Lactobacillus therapies
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
CA2374937A1 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
NZ536894A (en) 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
JP5453609B2 (ja) * 2001-12-20 2014-03-26 バイオラクティス インコーポレイティド 可鍛性タンパク質マトリクス及びその使用
KR20050094403A (ko) * 2002-12-13 2005-09-27 로레알 경구 투여로 피부의 피지 기능을 자극하기 위한 조성물제조에서의 카페인 제거 커피 원두 추출물의 용도
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PL1638414T3 (pl) * 2003-06-23 2009-12-31 Nestec Sa Mleko modyfikowane niemowlęce lub następne
WO2005112976A2 (en) * 2004-04-20 2005-12-01 The University Of Chicago Probiotic compounds from lactobacillus gg and uses therefor
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060233772A1 (en) * 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US9133249B2 (en) * 2006-10-24 2015-09-15 Vanderbilt University Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
WO2008127975A2 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
US20110039765A1 (en) * 2008-04-17 2011-02-17 Connor Ruth I Bioactive Molecules Produced by Probiotic Bacteria

Also Published As

Publication number Publication date
CA2772593A1 (en) 2011-03-17
WO2011031149A1 (en) 2011-03-17
PE20121557A1 (es) 2012-11-21
KR20120061836A (ko) 2012-06-13
TWI595090B (zh) 2017-08-11
MX345077B (es) 2017-01-16
TW201124529A (en) 2011-07-16
ECSP12011786A (es) 2012-07-31
AU2010293145A1 (en) 2012-03-08
CN102575224A (zh) 2012-07-11
EP2295535A1 (en) 2011-03-16
ES2614929T3 (es) 2017-06-02
US20110217402A1 (en) 2011-09-08
IN2012DN00951A (es) 2015-04-10
JP2013504321A (ja) 2013-02-07
EP2475764A1 (en) 2012-07-18
CA2772593C (en) 2018-11-27
AU2010293145B2 (en) 2016-04-14
SG178230A1 (en) 2012-03-29
EP2475764B1 (en) 2016-12-14
NZ597818A (en) 2014-01-31
BR112012005533A2 (pt) 2016-04-26
PL2475764T3 (pl) 2017-06-30
RU2012114190A (ru) 2013-10-20
MY160646A (en) 2017-03-15

Similar Documents

Publication Publication Date Title
MX2012002716A (es) Material no viable derivado de probioticos para la prevencion y tratamiento de la alergia.
NZ627915A (en) Probiotic derived non-viable material for infection prevention and treatment
CN104404092B (zh) 一种共轭亚油酸异构体的生物富集方法
CN106666318A (zh) 一种复合黑色植物花青素精华饮品及其制备方法
CN103844219A (zh) 一种提升柠檬多酚含量的发酵方法
CN104355908A (zh) 香菇培养基制备方法
CN104323228A (zh) 一种杏鲍菇调味液的制作方法
CN104756769A (zh) 一种香菇的培育方法
CN105876505A (zh) 一种风味核桃加工制作的方法
CN102805199B (zh) 制备鹿茸蛋白钙制品的方法
CN104187907B (zh) 芦荟槐花饮料
JP2008179573A (ja) 機能性組成物
CN105767794A (zh) 一种山楂雪梨羹
CN105394466A (zh) 一种家庭用韩式泡菜制作香料
CN108703361A (zh) 基于热爆预处理制备纯黑木耳或纯海带粉状发酵体的方法
CN108094539A (zh) 一种牡丹酸奶的制作方法
KR101049793B1 (ko) 상어 연골을 이용한 상어 연골액의 제조방법
CN106666705A (zh) 一种保健口服液
CN104306403A (zh) 一种纯蛇粉及其制备方法
CN103815368A (zh) 石耳清热解毒火锅调料及其生产方法
CN108236091A (zh) 一种魔芋块状食品的加工方法
CN103704822A (zh) 一种改善新陈代谢,增强机体免疫力的新型饮料
TW201023906A (en) The cultivation method for enhancing skin care capability of the anka rice fermented substance
KR20120049164A (ko) 면역밸런스제어제
CN103468525A (zh) 清热除湿酒的配方及生产方法

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: MJN U.S. HOLDINGS LLC

FG Grant or registration